683 Capital Management, LLC Applied Genetic Technologies Corp Transaction History

683 Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.94 - $8.19 $689,500 - $1.43 Million	-175,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.99 - $5.7 $755,303 - $1.08 Million	-189,299 Reduced 51.96%	175,000 $716,000
Q3 2020 Nov 16, 2020	SELL	$4.38 - $6.43 $528,670 - $776,107	-120,701 Reduced 24.89%	364,299 $1.77 Million
Q2 2020 Aug 14, 2020	SELL	$3.0 - $6.9 $150,000 - $345,000	-50,000 Reduced 9.35%	485,000 $2.69 Million
Q1 2020 May 15, 2020	SELL	$2.36 - $9.86 $53,888 - $225,143	-22,834 Reduced 4.09%	535,000 $1.76 Million
Q3 2019 Nov 14, 2019	BUY	$2.59 - $4.16 $926,790 - $1.49 Million	357,834 Added 178.92%	557,834 $2.32 Million
Q3 2018 Nov 14, 2018	SELL	$3.85 - $7.35 $385,000 - $735,000	-100,000 Reduced 33.33%	200,000 $1.46 Million
Q1 2018 May 15, 2018	BUY	$3.65 - $5.2 $306,483 - $436,633	83,968 Added 38.87%	300,000 $1.16 Million
Q4 2017 Feb 14, 2018	BUY	$3.4 - $4.15 $734,508 - $896,532	216,032	216,032 $778,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 683 Capital Management, LLC with notifications on news.